Mathieu Balaguer1,2, Aline Boisguerin3, Anaïs Galtier3, Nadège Gaillard3, Michèle Puech3,4, Virginie Woisard3,4,5. 1. Hôpitaux de Toulouse - Hôpital Larrey, Unité de la Voix et de la Déglutition / CCF, 24 chemin de Pouvourville, TSA 30030, 31059, Toulouse Cedex 9, France. mathieu.balaguer@univ-tlse3.fr. 2. IRIT, CNRS, University of Toulouse, Toulouse, France. mathieu.balaguer@univ-tlse3.fr. 3. Hôpitaux de Toulouse - Hôpital Larrey, Unité de la Voix et de la Déglutition / CCF, 24 chemin de Pouvourville, TSA 30030, 31059, Toulouse Cedex 9, France. 4. Oncopole, Toulouse, France. 5. Octogone-Lordat Interdisciplinary Research Unit (EA 4156), University of Toulouse II-Jean Jaurès, Toulouse, France.
Abstract
PURPOSE: Oral or oropharyngeal tumors degrade patients' speech quality because of their location. The treatment of these cancers also affects the functional outcomes, depending on type (surgery, radiotherapy, chemotherapy), volume resection (according the size of the tumor) or on the anatomical area treated, and the post-treatment delay. The aim of this work is to determine the factors influencing the chronic speech disorders (in terms of intelligibility and severity) of patients treated for an oral or oropharyngeal cancer. METHODS: Speech-perceptive assessment was led by a panel of six expert speech therapists, on a task of a description of a picture, presented to 87 patients. Clinical and treatment data were gathered by examining medical files. RESULTS: Intelligibility and severity scores in our population were 6.06 (interquartile range 4.2-8) and 7.61 (interquartile range 6.8-9.5) on a maximum of 10. After adjusting for age and anatomical region involved, multivariate analysis showed a principal impact of surgery on both intelligibility and severity, while the size of the tumor significantly affected the intelligibility score [- 143; 95% CI (- 2.21, - 0.65)]. These results are consistent with the definitions of intelligibility and severity of speech disorders. CONCLUSIONS: The lack of information on the impact of tumor location, however, requires more work to contribute to reducing impact on the quality of life of patients.
PURPOSE: Oral or oropharyngeal tumors degradepatients' speech quality because of their location. The treatment of these cancers also affects the functional outcomes, depending on type (surgery, radiotherapy, chemotherapy), volume resection (according the size of the tumor) or on the anatomical area treated, and the post-treatment delay. The aim of this work is to determine the factors influencing the chronic speech disorders (in terms of intelligibility and severity) of patients treated for an oral or oropharyngeal cancer. METHODS: Speech-perceptive assessment was led by a panel of six expert speech therapists, on a task of a description of a picture, presented to 87 patients. Clinical and treatment data were gathered by examining medical files. RESULTS: Intelligibility and severity scores in our population were 6.06 (interquartile range 4.2-8) and 7.61 (interquartile range 6.8-9.5) on a maximum of 10. After adjusting for age and anatomical region involved, multivariate analysis showed a principal impact of surgery on both intelligibility and severity, while the size of the tumor significantly affected the intelligibility score [- 143; 95% CI (- 2.21, - 0.65)]. These results are consistent with the definitions of intelligibility and severity of speech disorders. CONCLUSIONS: The lack of information on the impact of tumor location, however, requires more work to contribute to reducing impact on the quality of life of patients.
Entities:
Keywords:
Head and neck cancer; Intelligibility; Oral cavity cancer; Oropharyngeal cancer; Speech disorders
Authors: A S Denittis; M Machtay; D I Rosenthal; N J Sanfilippo; J H Lee; S Goldfeder; A A Chalian; G S Weinstein; R S Weber Journal: Am J Otolaryngol Date: 2001 Sep-Oct Impact factor: 1.808
Authors: Alex M Mlynarek; Jana M Rieger; Jeffrey R Harris; Daniel A O'Connell; Khalid H Al-Qahtani; Khalid Ansari; Jason Chau; Hadi Seikaly Journal: J Otolaryngol Head Neck Surg Date: 2008-02
Authors: Raghav C Dwivedi; Rehan A Kazi; Nishant Agrawal; Christopher M Nutting; Peter M Clarke; Cyrus J Kerawala; Peter H Rhys-Evans; Kevin J Harrington Journal: Cancer Treat Rev Date: 2009-05-29 Impact factor: 12.111
Authors: F Stelzle; C Knipfer; M Schuster; T Bocklet; E Nöth; W Adler; L Schempf; P Vieler; M Riemann; F W Neukam; E Nkenke Journal: Int J Oral Maxillofac Surg Date: 2013-07-08 Impact factor: 2.789
Authors: Pepijn A Borggreven; Irma M Verdonck-de Leeuw; Martin J Muller; Milou L C H Heiligers; Remco de Bree; Neil K Aaronson; C René Leemans Journal: Eur Arch Otorhinolaryngol Date: 2007-02-02 Impact factor: 2.503